UMDNJ-New Jersey Medical School is a clinical research site located in Newark, New Jersey, United States 07103.
Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.
UMDNJ-New Jersey Medical School has participated in 20 clinical trials with 1 currently active.
Therapeutic areas: Stage IV Pancreatic Cancer, Prostate Adenocarcinoma, Stage I Prostate Cancer.
Sponsors: Halozyme Therapeutics, National Cancer Institute (NCI), Radiation Therapy Oncology Group.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New Jersey · View every site in Newark
Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UMDNJ-New Jersey Medical School has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UMDNJ-New Jersey Medical School has 20 clinical trials on record, with 1 currently active. Their work covers Stage IV Pancreatic Cancer, Prostate Adenocarcinoma, Stage I Prostate Cancer.
UMDNJ-New Jersey Medical School has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.